Republic Report earlier reported that the Consumer Healthcare Products Association (CHPA), an industry group representing over the counter drug makers, spent a whopping $194,957.76 in Kentucky in January alone lobbying against stricter regulations on the sales of certain cold medicines that can be used to produce methamphetamine.
The CHPA is also lobbying heavily in Oklahoma, and scored a victory earlier this week when the House Public Health Committee there defeated a bill along a 7-6 vote that would’ve enacted regulations similar to the ones Kentucky legislators are proposing. Rep. Doug Cox (R), a supporter of the bill, …
Help follow the money
tips@republicreport.org
Bad Behavior has blocked 761 access attempts in the last 7 days.
